Laparoscopic TAP Block in TEP Inguinal Hernia Repair.Phase 3NCT02632136
Lap TAP Block for Laparoscopic TEP Inguinal Hernia Repair: a Prospective, Double-blinded, Randomized, Clinical Trial
A Phase 3 study testing TAP Block Group and Peri-Portal Block Group in people with Laparoscopic TAP Block in TEP Inguinal Hernia Repair., run by Mayo General Hospital, Ireland at 1 site in Ireland.
Trial summary
A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Laparoscopic TAP Block in TEP Inguinal Hernia Repair.
- What is being tested?
- TAP Block Group and Peri-Portal Block Group
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 86 participants
- Where
- 1 siteIreland
- Study dates
- Nov 2015to Nov 2016
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All consecutive ASA grade I-II- III patients undergoing elective unilateral laparoscopic total extra peritoneal (TEP) Inguinal hernia repair
- Age 18 - 80 yrs, including those who are having recurrent inguinal hernia repair.
Who cannot join
- ASA grade IV, V
- Bilateral inguinal hernia repair
- BMI > 40 kg/m2
- Converted to open procedures.
- Conversion to Transabdominal preperitoneal (TAPP) repair
- Coagulopathy.
Show all 10Show fewer
- Allergy to Bupivacaine.
- Diagnosis of "chronic pain syndrome".
- Known alcohol or substance abuse within the last 6 months.
- Daily Opioid intake.
Trial locations and contacts
1 site in 1 country.
Ireland1 site, 1 recruiting
- Recruiting
Mayo University Hospital
Castlebar, Mayo, F23 EH39
Asif Khan, MBBS, MRCSI, 00353894171595, asif_21khan@yahoo.com
Iqbal Z Khan, MRCSI, FRCSI, 00353868214999, iqbalzkhan@hotmail.com
About this study
Official title: Laparoscopic-assisted Transversus Abdominis Plane (TAP) Block for Laparoscopic Total Extra Peritoneal (TEP) Inguinal Hernia Repair: a Prospective, Double-blinded, Randomized, Clinical Trial
A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Our alternative hypothesis is that laparoscopic-assisted TAP block is better than the periportal wound infiltration in controlling the postoperative pain.
Read the detailed description
Hypothesis:
A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Our alternative hypothesis is that laparoscopic-assisted TAP block is better than the periportal wound infiltration in controlling the postoperative pain.
Significance of the study:
Postoperative pain control is very important in day case surgery. Use of local anaesthetics has a significant role in this scenario.
No study to date examines the use of laparoscopically delivered TAP blocks in TEP hernia repairs. This technique is more reliable, solely performed by surgeons, and is supposed to replace the ultrasound-guided method. The latter is time-consuming, need ultrasound skills and is usually done by anaesthetists. Previous reports have shown advantage for the ultrasound-guided TAP block in controlling postoperative pain for several types of surgery. Our previous study for use of laparoscopically delivered TAP block in Laparoscopic Cholecystectomy has shown significant advantage in pain relief.
Among these, four trials have examined the beneficial effect of TAP block for inguinal hernia repair. Two studies controlled against placebo or no block groups, one compared TAP block with periportal infiltration, while another study compared single injection TAP block with continuous TAP block. Three studies used ultrasound to deliver the block. The Fourth study used semi-blind TAP blocks. One of the studies included open inguinal hernia repair as well.
The current trial is supposed to be the first one to evaluate the new method and comparing it with the current practice. In addition, the investigators will be using multi-modal analgesia.
Methodology:
Settings:
The study will be conducted in the Department of General surgery at Mayo University Hospital, Ireland.
Study design:
The current study is a prospective, randomized, Double-blinded parallel trial.
Study population:
Eighty six consecutive patients undergoing laparoscopic inguinal hernia repair (TEP) will be included in the study, 43 patients is each arm. One group will have surgically-assisted TAP block with bupivacaine and the others will have peri-portal local anesthetic infiltration. The patients will be randomized into two groups using "random number table" technique. The postoperative pain scoring will be recorded by two observers using numerical analog scale (NAS), but neither the patients nor the observers will be informed about the type of analgesia used.
Informed consent will be sought from all patients, and ethical approval will be sought from the institutional review board. The study will meet the standards outlined in the Declaration of Helsinki and Good practices. The trial will be registered at www.clinicaltrials.gov.
Sample size calculation:
SD of pain score = 1.83 (previous report by Mun Gyu Kim et al). Power = 90%. α = 0.05. Sample size per group = 43.
Surgery:
The surgery will be performed by one general surgeon following standardized surgical approach under general anaesthesia, while the TAP block will be done by one of the two surgeons who are familiar with the technique. The intra-abdominal pressure will be set at the same level (15 mm Hg) for all patients.
Intervention:
Test group:
The TAP block will be performed at lumbar triangle of petit (Triangle bounded by latissmus dorsi posteriorly, external oblique anteriorly and base by iliac crest) using a blunt needle. Local anaesthetic is injected at midaxillary line after establishing the space of Bogros (space between peritoneum and transversalis fascia). All the procedure will be performed under direct visualization of the laparoscope. Digital pressure will applied to define the site of injection. The needle will be inserted at the site of injection till it is short of transversalis fascia and slight tenting is visible . Then the plunger will be withdrawn to exclude vascular placement and the injection will be employed. The site of injection will be inspected from within the space of Bogros. The presence of internal bulge is regarded as the definitive point of the procedure.
Control group:
Local periportal infiltration will be done at the three ports before the insertion of ports.
Dosing:
Fixed dose of Bupivacaine (Total: 30 ml of 0.25% for the Test group and 15 ml of 0.5% for control group) will be given to all patients.
Test group: Angle of Petit ---- 30 ml of 0.25%. Control group: Camera port ---- 7 ml of 0.5%. Other ports ---- 4 ml of 0.5% each.
.
Postoperative pain management:
Standardized analgesic regimen will be used in the postoperative period. All patients will receive paracetamol 1000 mg / 6 hourly, orally + Dexketoprofen 50 mg (at 8 hrs).
For rescue analgesia: Tapentadol 75 mg/ As required. Total opiods used in peri operative period will be recorded.
Double blinding:
The patient and the observer will not know the control or intervention group.
Study end-points:
Primary: Pain score at rest and while coughing using the Numerical analog scale (NAS) at 1, 3, 6 and 24 hr.
Secondary: Analgesics requirements ( Paracetamol, NSAID and opiods). Nausea and vomiting.
Statistical analysis:
Group comparison will be done using Student t-test (2-tailed), Pearson chi-square test, and Mann-Whitney test. Alpha will be set at 0.05, and the SSPS 17.0 will be used for the analysis.
- Being tested
- TAP Block Group, Peri-Portal Block Group
- Keywords
- Laparoscopic, TAP Block, Total extra peritoneal Inguinal hernia repair
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TAP Block GroupDrug
Also called 0.25% Bupivacaine
Transversus Abdominus Plane (TAP) block: Bupivacaine (30 ml of 0.25%)is injected between internal oblique and transveralis facia. The location of needle and the bleb that is formed after the injection is inspected under diect laparoscopic vision.
Peri-Portal Block GroupDrug
Also called 0.5% Bupivacaine
15 ml of 0.5% Bupivacaine is injected in the skin and subcutaneous tissue before inserting the ports. 7 ml out of it is injected at sub-umblical port and 4 ml each a the site of other two ports.
| Study group | Role | What they receive |
|---|---|---|
| TAP block group | Active comparator | This group will receive 30 ml of 0.25% Bupivacine given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine.
They will also receive normal saline injections at port sites, which will be injected before the ports are inserted. 15 ml of normal saline will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports. Receives: Drug: TAP Block Group |
| Peri-Portal block Group | Placebo comparator | They will receive 0.5% Bupivacaine injections at port sites, which will be injected before the ports are inserted. 15 ml of 0.5% Bupivacaine will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports.
This group will also receive 30 ml of Normal Saline Injection given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine. Receives: Drug: Peri-Portal Block Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Scores
Numerical Analogue score for pain will be recorded at 1, 3, 6 and 24 hours post surgery
Measured: Within 24 hours post surgery
Secondary outcomes (2)
Total opioid usage
amount of opioids used in perioperative period will be recorded.
Measured: within 24 hours perioperative period
Post operative nausea or vomiting
instances of nausea or vomiting in the post operative period will be recorded
Measured: 24 hours post operative period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Dec 2015 (estimated)
- Study startNov 2015
- Primary completionNov 2016 (estimated)
- Study completionNov 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Laparoscopic TAP Block in TEP Inguinal Hernia Repair.Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 86 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mayo General Hospital, Ireland
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asif Khan, Mayo General Hospital, Ireland
- Investigators
- Asif Khan, MBBS, MRCSI, Principal investigator, Mayo University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02632136
- Sponsor's protocol ID
- MGHIreland
- Status last verified
- Dec 2015
- First submitted
- 13 Dec 2015
- Last updated
- 16 Dec 2015
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Yes
Publications
Elamin G, Waters PS, Hamid H, O'Keeffe HM, Waldron RM, Duggan M, Khan W, Barry MK, Khan IZ. Efficacy of a Laparoscopically Delivered Transversus Abdominis Plane Block Technique during Elective Laparoscopic Cholecystectomy: A Prospective, Double-Blind Randomized Trial. J Am Coll Surg. 2015 Aug;221(2):335-44. doi: 10.1016/j.jamcollsurg.2015.03.030. Epub 2015 Mar 27.
PubMed 25899736Chetwood A, Agrawal S, Hrouda D, Doyle P. Laparoscopic assisted transversus abdominis plane block: a novel insertion technique during laparoscopic nephrectomy. Anaesthesia. 2011 Apr;66(4):317-8. doi: 10.1111/j.1365-2044.2011.06664.x. No abstract available.
PubMed 21401554Kim MG, Kim SI, Ok SY, Kim SH, Lee SJ, Park SY, Yoo JH, Cho A, Hur KY, Kim MJ. Is transverse abdominis plane block effective following local anesthetic infiltration in laparoscopic totally extraperitoneal hernia repair? Korean J Anesthesiol. 2014 Dec;67(6):398-403. doi: 10.4097/kjae.2014.67.6.398. Epub 2014 Dec 29.
PubMed 25558340
Study at a glance
From the registry record, last updated by the sponsor on 16 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Laparoscopic-assisted Transversus Abdominis Plane (TAP) Block for Laparoscopic Total Extra Peritoneal (TEP) Inguinal Hernia Repair: a Prospective, Double-blinded, Randomized, Clinical Trial
- ClinicalTrials.gov ID
- NCT02632136
- Acronym / sponsor ID
- MGHIreland
- Keywords
- Laparoscopic, TAP Block, Total extra peritoneal Inguinal hernia repair
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 86 participants (estimated)
- Lead sponsor
- Mayo General Hospital, IrelandUniversity, hospital or other
- Study start
- Nov 2015
- Primary completion
- Nov 2016 (estimated)
- Study completion
- Nov 2016 (estimated)
- First posted
- 16 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Our alternative hypothesis is that laparoscopic-assisted TAP block is better than the periportal wound infiltration in controlling the postoperative pain.
Detailed description
Hypothesis:
A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Our alternative hypothesis is that laparoscopic-assisted TAP block is better than the periportal wound infiltration in controlling the postoperative pain.
Significance of the study:
Postoperative pain control is very important in day case surgery. Use of local anaesthetics has a significant role in this scenario.
No study to date examines the use of laparoscopically delivered TAP blocks in TEP hernia repairs. This technique is more reliable, solely performed by surgeons, and is supposed to replace the ultrasound-guided method. The latter is time-consuming, need ultrasound skills and is usually done by anaesthetists. Previous reports have shown advantage for the ultrasound-guided TAP block in controlling postoperative pain for several types of surgery. Our previous study for use of laparoscopically delivered TAP block in Laparoscopic Cholecystectomy has shown significant advantage in pain relief.
Among these, four trials have examined the beneficial effect of TAP block for inguinal hernia repair. Two studies controlled against placebo or no block groups, one compared TAP block with periportal infiltration, while another study compared single injection TAP block with continuous TAP block. Three studies used ultrasound to deliver the block. The Fourth study used semi-blind TAP blocks. One of the studies included open inguinal hernia repair as well.
The current trial is supposed to be the first one to evaluate the new method and comparing it with the current practice. In addition, the investigators will be using multi-modal analgesia.
Methodology:
Settings:
The study will be conducted in the Department of General surgery at Mayo University Hospital, Ireland.
Study design:
The current study is a prospective, randomized, Double-blinded parallel trial.
Study population:
Eighty six consecutive patients undergoing laparoscopic inguinal hernia repair (TEP) will be included in the study, 43 patients is each arm. One group will have surgically-assisted TAP block with bupivacaine and the others will have peri-portal local anesthetic infiltration. The patients will be randomized into two groups using "random number table" technique. The postoperative pain scoring will be recorded by two observers using numerical analog scale (NAS), but neither the patients nor the observers will be informed about the type of analgesia used.
Informed consent will be sought from all patients, and ethical approval will be sought from the institutional review board. The study will meet the standards outlined in the Declaration of Helsinki and Good practices. The trial will be registered at www.clinicaltrials.gov.
Sample size calculation:
SD of pain score = 1.83 (previous report by Mun Gyu Kim et al). Power = 90%. α = 0.05. Sample size per group = 43.
Surgery:
The surgery will be performed by one general surgeon following standardized surgical approach under general anaesthesia, while the TAP block will be done by one of the two surgeons who are familiar with the technique. The intra-abdominal pressure will be set at the same level (15 mm Hg) for all patients.
Intervention:
Test group:
The TAP block will be performed at lumbar triangle of petit (Triangle bounded by latissmus dorsi posteriorly, external oblique anteriorly and base by iliac crest) using a blunt needle. Local anaesthetic is injected at midaxillary line after establishing the space of Bogros (space between peritoneum and transversalis fascia). All the procedure will be performed under direct visualization of the laparoscope. Digital pressure will applied to define the site of injection. The needle will be inserted at the site of injection till it is short of transversalis fascia and slight tenting is visible . Then the plunger will be withdrawn to exclude vascular placement and the injection will be employed. The site of injection will be inspected from within the space of Bogros. The presence of internal bulge is regarded as the definitive point of the procedure.
Control group:
Local periportal infiltration will be done at the three ports before the insertion of ports.
Dosing:
Fixed dose of Bupivacaine (Total: 30 ml of 0.25% for the Test group and 15 ml of 0.5% for control group) will be given to all patients.
Test group: Angle of Petit ---- 30 ml of 0.25%. Control group: Camera port ---- 7 ml of 0.5%. Other ports ---- 4 ml of 0.5% each.
.
Postoperative pain management:
Standardized analgesic regimen will be used in the postoperative period. All patients will receive paracetamol 1000 mg / 6 hourly, orally + Dexketoprofen 50 mg (at 8 hrs).
For rescue analgesia: Tapentadol 75 mg/ As required. Total opiods used in peri operative period will be recorded.
Double blinding:
The patient and the observer will not know the control or intervention group.
Study end-points:
Primary: Pain score at rest and while coughing using the Numerical analog scale (NAS) at 1, 3, 6 and 24 hr.
Secondary: Analgesics requirements ( Paracetamol, NSAID and opiods). Nausea and vomiting.
Statistical analysis:
Group comparison will be done using Student t-test (2-tailed), Pearson chi-square test, and Mann-Whitney test. Alpha will be set at 0.05, and the SSPS 17.0 will be used for the analysis.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| TAP block group | Active comparator | Drug: TAP Block GroupThis group will receive 30 ml of 0.25% Bupivacine given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine. They will also receive normal saline injections at port sites, which will be injected before the ports are inserted. 15 ml of normal saline will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports. |
| Peri-Portal block Group | Placebo comparator | Drug: Peri-Portal Block GroupThey will receive 0.5% Bupivacaine injections at port sites, which will be injected before the ports are inserted. 15 ml of 0.5% Bupivacaine will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports. This group will also receive 30 ml of Normal Saline Injection given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All consecutive ASA grade I-II- III patients undergoing elective unilateral laparoscopic total extra peritoneal (TEP) Inguinal hernia repair
- Age 18 - 80 yrs, including those who are having recurrent inguinal hernia repair.
Key exclusion criteria (10 listed)
- ASA grade IV, V
- Bilateral inguinal hernia repair
- BMI > 40 kg/m2
- Converted to open procedures.
- Conversion to Transabdominal preperitoneal (TAPP) repair
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TAP Block GroupAlso: 0.25% BupivacaineTransversus Abdominus Plane (TAP) block: Bupivacaine (30 ml of 0.25%)is injected between internal oblique and transveralis facia. The location of needle and the bleb that is formed after the injection is inspected under diect laparoscopic vision. | Drug | TAP block group |
| Peri-Portal Block GroupAlso: 0.5% Bupivacaine15 ml of 0.5% Bupivacaine is injected in the skin and subcutaneous tissue before inserting the ports. 7 ml out of it is injected at sub-umblical port and 4 ml each a the site of other two ports. | Drug | Peri-Portal block Group |
Primary outcome
Pain Scores
Time frame: Within 24 hours post surgery
Numerical Analogue score for pain will be recorded at 1, 3, 6 and 24 hours post surgery
2 secondary outcomes
Total opioid usage
Time frame: within 24 hours perioperative period
Post operative nausea or vomiting
Time frame: 24 hours post operative period
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Dec 2015.
- Background: PubMed 25899736Elamin G, Waters PS, Hamid H, O'Keeffe HM, Waldron RM, Duggan M, Khan W, Barry MK, Khan IZ. Efficacy of a Laparoscopically Delivered Transversus Abdominis Plane Block Technique during Elective Laparoscopic Cholecystectomy: A Prospective, Double-Blind Randomized Trial. J Am Coll Surg. 2015 Aug;221(2):335-44. doi: 10.1016/j.jamcollsurg.2015.03.030. Epub 2015 Mar 27.
- Results publication: PubMed 21401554Chetwood A, Agrawal S, Hrouda D, Doyle P. Laparoscopic assisted transversus abdominis plane block: a novel insertion technique during laparoscopic nephrectomy. Anaesthesia. 2011 Apr;66(4):317-8. doi: 10.1111/j.1365-2044.2011.06664.x. No abstract available.
- Results publication: PubMed 25558340Kim MG, Kim SI, Ok SY, Kim SH, Lee SJ, Park SY, Yoo JH, Cho A, Hur KY, Kim MJ. Is transverse abdominis plane block effective following local anesthetic infiltration in laparoscopic totally extraperitoneal hernia repair? Korean J Anesthesiol. 2014 Dec;67(6):398-403. doi: 10.4097/kjae.2014.67.6.398. Epub 2014 Dec 29.
- Individual participant dataSharing planned: Yes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Asif Khan, MBBS, MRCSI principal investigator
Mayo University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing TAP Block Group and Peri-Portal Block Group in people with Laparoscopic TAP Block in TEP Inguinal Hernia Repair., run by Mayo General Hospital, Ireland at 1 site in Ireland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Asif Khan, MBBS, MRCSI (00353894171595, asif_21khan@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Scores (time frame: Within 24 hours post surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02632136, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2015.